Positions & consultation responses
Europe has the science, talent, and ambition to lead globally in biotech and healthcare, but to secure that leadership and potential, we must build the conditions that make innovation, capital, and people to start, scale and remain in Europe. In this paper, Invest Europe highlights how to strengthen Europe’s biotech and healthcare ecosystem: unlocking investment at every stage, ensuring public funding complements private capital, promoting smarter and harmonised regulation, creating a competitive end-user market for innovation, harnessing technology and data that accelerate discovery, and strengthening the entrepreneurial workforce - to deliver world-class breakthroughs that drive prosperity, resilience, and better health.
Response to the European Commission Consultation on the EU life sciences strategy
Positions & consultation responses
16 Apr 2025
Position Paper on Investment Omnibus proposal
Positions & consultation responses
18 Mar 2025
Response to the EC consultation on venture capital
Positions & consultation responses
09 Aug 2011
MEMBER ONLY
EVCA Corporate Venturing European Activity Report 2002
Positions & consultation responses
01 Oct 2003
Position Paper on European Competitiveness Fund (EU Budget for VC)
Positions & consultation responses
08 Jul 2026
Response to EC Consultation on General Block Exemption Rule
Positions & consultation responses
09 Dec 2021
Letter to the European Commission on public support to SMEs backed by private equity
Positions & consultation responses
01 Apr 2020
Invest Europe Leader Interviews: Dr. Rafaèle Tordjman, Jeito Capital
Videos
26 Sep 2024
Position paper on EU response to the US Inflation Reduction Act
Positions & consultation responses
16 Mar 2023
Position on the Undertaking in Difficulty (UID) definition
Positions & consultation responses
01 Sep 2026
Response to the European Commission’s targeted survey on simplifying the General Block Exemption Regulation (GBER)
Positions & consultation responses
02 Jul 2026
Position on the draft 2027-2034 General Block Exemption Regulation (GBER)
Positions & consultation responses
17 Apr 2026